© 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.Peer reviewedPostprin
OBJECTIVE: To review the prospective evidence surrounding the issue of tight glycemic control in peo...
Objective: To investigate the association between visit-to-visit HbA1c variability and cardiovascula...
BackgroundGlycosylated haemoglobin (HbA1c) measurement is used to diagnose and to guide treatment of...
OBJECTIVE Glycemic variability is emerging as a measure of glycemic control, which may be a reliable...
Glucose variability has been identified as a potential risk factor for diabetic complications; oxida...
Background: Current practice uses the latest measure of glycated hemoglobin (HbA1c) to facilitate cl...
Aims: The aim of the present study was to evaluate, by means of a meta-analysis approach, whether ne...
Aims: To investigate whether long-term glycaemic variability (GV) is associated with vascular compli...
. These authors contributed equally to this work. Objective: To explore the association between glyc...
demonstrated that intensive therapy aimed at improved glucose control markedly reduced the risk of d...
OBJECTIVE To investigate the association between visit-to-visit HbA1c variability and cardiovascular...
BackgroundGlycosylated haemoglobin (HbA1c) measurement is used to diagnose and to guide treatment of...
OBJECTIVE: Diabetes mellitus (DM) guidelines focus on target glycated hemoglobin (HbA1c) levels. Lon...
Purpose of Review: Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease glo...
OBJECTIVE The Diabetes Control and Complications Trial (DCCT) demonstrated the beneficial effects of...
OBJECTIVE: To review the prospective evidence surrounding the issue of tight glycemic control in peo...
Objective: To investigate the association between visit-to-visit HbA1c variability and cardiovascula...
BackgroundGlycosylated haemoglobin (HbA1c) measurement is used to diagnose and to guide treatment of...
OBJECTIVE Glycemic variability is emerging as a measure of glycemic control, which may be a reliable...
Glucose variability has been identified as a potential risk factor for diabetic complications; oxida...
Background: Current practice uses the latest measure of glycated hemoglobin (HbA1c) to facilitate cl...
Aims: The aim of the present study was to evaluate, by means of a meta-analysis approach, whether ne...
Aims: To investigate whether long-term glycaemic variability (GV) is associated with vascular compli...
. These authors contributed equally to this work. Objective: To explore the association between glyc...
demonstrated that intensive therapy aimed at improved glucose control markedly reduced the risk of d...
OBJECTIVE To investigate the association between visit-to-visit HbA1c variability and cardiovascular...
BackgroundGlycosylated haemoglobin (HbA1c) measurement is used to diagnose and to guide treatment of...
OBJECTIVE: Diabetes mellitus (DM) guidelines focus on target glycated hemoglobin (HbA1c) levels. Lon...
Purpose of Review: Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease glo...
OBJECTIVE The Diabetes Control and Complications Trial (DCCT) demonstrated the beneficial effects of...
OBJECTIVE: To review the prospective evidence surrounding the issue of tight glycemic control in peo...
Objective: To investigate the association between visit-to-visit HbA1c variability and cardiovascula...
BackgroundGlycosylated haemoglobin (HbA1c) measurement is used to diagnose and to guide treatment of...